316 related articles for article (PubMed ID: 17888421)
21. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
[TBL] [Abstract][Full Text] [Related]
22. Antithrombin III prevents concanavalin A-induced liver injury through inhibition of macrophage inflammatory protein-2 release and production of prostacyclin in mice.
Nakamura K; Ito T; Yoneda M; Takamoto S; Nakade Y; Okamoto S; Okada M; Yokohama S; Aso K; Makino I
J Hepatol; 2002 Jun; 36(6):766-73. PubMed ID: 12044526
[TBL] [Abstract][Full Text] [Related]
23. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
[TBL] [Abstract][Full Text] [Related]
24. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice.
Miyazawa Y; Tsutsui H; Mizuhara H; Fujiwara H; Kaneda K
Hepatology; 1998 Feb; 27(2):497-506. PubMed ID: 9462649
[TBL] [Abstract][Full Text] [Related]
25. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
Leoni F; Zaliani A; Bertolini G; Porro G; Pagani P; Pozzi P; Donà G; Fossati G; Sozzani S; Azam T; Bufler P; Fantuzzi G; Goncharov I; Kim SH; Pomerantz BJ; Reznikov LL; Siegmund B; Dinarello CA; Mascagni P
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2995-3000. PubMed ID: 11867742
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.
Ludwig JM; Zhang Y; Chamulitrat W; Stremmel W; Pathil A
PLoS One; 2018; 13(5):e0197836. PubMed ID: 29795632
[TBL] [Abstract][Full Text] [Related]
27. Effects of chenodeoxycholic and ursodeoxycholic acids on interferon-gamma production by peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
Saeki R; Ogino H; Kaneko S; Unoura M; Kobayashi K
J Gastroenterol; 1995 Dec; 30(6):739-44. PubMed ID: 8963391
[TBL] [Abstract][Full Text] [Related]
28. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
Louis H; Le Moine O; Peny MO; Quertinmont E; Fokan D; Goldman M; Devière J
Hepatology; 1997 Jun; 25(6):1382-9. PubMed ID: 9185757
[TBL] [Abstract][Full Text] [Related]
29. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells.
Sakai N; Van Sweringen HL; Belizaire RM; Quillin RC; Schuster R; Blanchard J; Burns JM; Tevar AD; Edwards MJ; Lentsch AB
J Gastroenterol Hepatol; 2012 Oct; 27(10):1609-16. PubMed ID: 22646996
[TBL] [Abstract][Full Text] [Related]
31. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
Iwaki T; Ishizaki K; Kinoshita S; Tanaka H; Fukunari A; Tsurufuji M; Imada T
World J Gastroenterol; 2007 Oct; 13(37):5003-8. PubMed ID: 17854144
[TBL] [Abstract][Full Text] [Related]
33. Shikonin Attenuates Concanavalin A-Induced Acute Liver Injury in Mice via Inhibition of the JNK Pathway.
Liu T; Xia Y; Li J; Li S; Feng J; Wu L; Zhang R; Xu S; Cheng K; Zhou Y; Zhou S; Dai W; Chen K; Wang F; Lu J; Zhou Y; Guo C
Mediators Inflamm; 2016; 2016():2748367. PubMed ID: 27293314
[TBL] [Abstract][Full Text] [Related]
34. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
Tukov FF; Luyendyk JP; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
[TBL] [Abstract][Full Text] [Related]
35. Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression.
Tu CT; Han B; Yao QY; Zhang YA; Liu HC; Zhang SC
Int Immunopharmacol; 2012 Jan; 12(1):151-7. PubMed ID: 22138522
[TBL] [Abstract][Full Text] [Related]
36. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
[TBL] [Abstract][Full Text] [Related]
37. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
Nowak G; Norén UG; Wernerson A; Marschall HU; Möller L; Ericzon BG
Transpl Int; 2005 May; 17(12):804-9. PubMed ID: 15815896
[TBL] [Abstract][Full Text] [Related]
38. (-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury.
Wang Y; Mei Y; Feng D; Xu L
Clin Exp Immunol; 2006 Sep; 145(3):485-92. PubMed ID: 16907918
[TBL] [Abstract][Full Text] [Related]
39. [Protective effects of Angelica sinensis polysaccharide on immunological liver injury induced by concanavalin A in mice].
Yu F
Zhong Yao Cai; 2009 Oct; 32(10):1580-3. PubMed ID: 20112726
[TBL] [Abstract][Full Text] [Related]
40. [The effects of agmatine on acute peritoneal inflammatory injury and neutrophil infiltration induced by zymosan in mice].
Deng J; Tian L; Ma X; Fan X; Hou F; Liang H; Luo Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):225-9. PubMed ID: 29916686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
